Thursday – May 28, 2009
1:45 pm – 3:00 pm
George Stamatoyannopoulos Lecture

Brian J. Druker, MD, Director, Oregon Health and Science University Knight Cancer Institute
Imatinib as a Paradigm of Molecularly Targeted Cancer Therapies

Friday – May 29, 2009
8:00 am – 9:15 am
Outstanding Achievement Award

Inder Verma, PhD, American Cancer Society Professor of Molecular Biology, The Salk Institute
25 Years of Gene Therapy: Ups and Downs

Saturday – May 30, 2009
2:30 pm – 5:00 pm
Presidential Symposium

John Carpten, PhD, Senior Investigator & Director, the Translational Genomics Research Institute (T-Gen)
Interrogation of Cancer Genomes for the Discovery of Novel Therapeutic Targets

John J. Nemunaitis, MD, Executive Director, Mary Crowley Medical Research Center
Personalized Cancer Gene Therapy

Helen E. Heslop, MD, Professor, Department of Pediatrics and Medicine at the Baylor College of Medicine
Immunotherapy of Viral Infections and Malignancy

Chiara Bonini, MD, Cancer Immunotherapy and Gene Therapy Program, Fondazione Centro S. Raffaele
Del Monte Tabor
T-cell Based Gene Therapy to Improve Hematopoietic Stem Cell Transplantation